Advertisement
UK markets close in 2 hours 30 minutes
  • FTSE 100

    8,038.34
    +14.47 (+0.18%)
     
  • FTSE 250

    19,700.24
    +100.85 (+0.51%)
     
  • AIM

    753.29
    +4.11 (+0.55%)
     
  • GBP/EUR

    1.1610
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2391
    +0.0041 (+0.33%)
     
  • Bitcoin GBP

    53,341.46
    +122.58 (+0.23%)
     
  • CMC Crypto 200

    1,420.16
    +5.40 (+0.38%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    80.99
    -0.91 (-1.11%)
     
  • GOLD FUTURES

    2,323.80
    -22.60 (-0.96%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,053.98
    +193.18 (+1.08%)
     
  • CAC 40

    8,078.32
    +37.96 (+0.47%)
     

FDA Accepts Application for Bristol-Myers Squibb and bluebird bio's Multiple Myeloma CAR-T Therapy

FDA Accepts Application for Bristol-Myers Squibb and bluebird bio's Multiple Myeloma CAR-T Therapy

The Food and Drug Administration's acceptance means it will issue a go/no-go decision on ide-cel in March 2021.